13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 26 holding rows worth $1,584,219,000.
- Accession
- 0001085146-19-001618
- Filer
- CIK 1544773
- Filed
- 2019-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 26 entries on the cover page, a total value of $1,584,219,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,584,219,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 10,990,975 | $228,173,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 1,225,387 | $143,824,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 3,652,134 | $139,000,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 1,985,460 | $118,433,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 3,309,206 | $109,866,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 4,032,123 | $91,247,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 17,875,655 | $91,166,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 1,696,773 | $80,597,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 4,258,358 | $78,354,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 4,288,092 | $75,084,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,759,324 | $64,989,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,608,784 | $44,949,000 | thousands by filing date | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 3,747,453 | $43,995,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 3,478,261 | $43,096,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 2,124,619 | $36,905,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 11,627,900 | $30,698,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 5,158,884 | $30,128,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 4,222,558 | $27,447,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,666,667 | $23,150,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 3,093,690 | $22,800,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 4,588,352 | $17,390,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 1,430,579 | $11,716,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,140,000 | $10,841,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 142,943 | $10,083,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469AA6 | NOTE | 9,000,000 | $7,503,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 145,000 | $2,785,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-19-001618 | this filing | 2019-05-15 | acceptance time not in the bulk data set |